Search

Your search keyword '"RC648-665"' showing total 1,134 results

Search Constraints

Start Over You searched for: Descriptor "RC648-665" Remove constraint Descriptor: "RC648-665" Publisher bmj publishing group Remove constraint Publisher: bmj publishing group
1,134 results on '"RC648-665"'

Search Results

1. Effect of weight-maintaining ketogenic diet on glycemic control and insulin sensitivity in obese T2D subjects

2. National health and economic impact of a lifestyle program to prevent type 2 diabetes mellitus in Germany: a simulation study

3. Recent trends in GLP-1 RA and SGLT2i use among people with type 2 diabetes and atherosclerotic cardiovascular disease in the USA

4. Ethnic-specific oral glucose tolerance (OGTT) phenotypes in women with hyperglycemia in pregnancy

5. Applying machine learning approaches for predicting obesity risk using US health administrative claims database

6. Presentation and characteristics of children with screen-detected type 1 diabetes: learnings from the ELSA general population pediatric screening study

7. Serum isthmin-1 is a potential biomarker for metabolic dysfunction associated fatty liver disease in patients with metabolic syndrome and type 2 diabetes mellitus

8. Investigation of end-stage kidney disease risk prediction in an ethnically diverse cohort of people with type 2 diabetes: use of kidney failure risk equation

9. Association between personality, lifestyle behaviors, and cardiovascular diseases in type 2 diabetes mellitus: a population-based cohort study of UK Biobank data

10. Increased incidence of neurodegenerative diseases in Finnish individuals with type 1 diabetes

11. Development of a three-dimensional scoring model for the assessment of continuous glucose monitoring data in type 1 diabetes

12. Not all healthcare inequities in diabetes are equal: a comparison of two medically underserved cohorts

13. Ethnic differences in the manifestation of early-onset type 2 diabetes

14. Combined impact of heat and dust on diabetes hospitalization in Kuwait

15. Adipose tissue–derived adipsin marks human aging in non-type 2 diabetes population

16. Glucokinase activators and imeglimin: new weaponry in the armamentarium against type 2 diabetes

17. Rate and risk factors of kidney function decline among South Asians with type 2 diabetes: analysis of the CARRS Trial

18. Metabolic features of neutrophilic differentiation of HL-60 cells in hyperglycemic environments

19. Real-world study of the multimorbidity and health service utilisation among individuals with non-diabetic hyperglycemia and type 2 diabetes mellitus in North West London

20. Risk of healthcare visits from influenza in subjects with diabetes and impacts of early vaccination

21. Changes in use and hospital outcomes of bariatric surgery in Spain (2016–2022): analysis of the role of type 2 diabetes using propensity score matching

22. Cardiovascular disease risk factors and their associations with inflammation among US adolescents: NHANES, 2015 to March 2020

23. Impact of mitigating obesity, smoking, and physical inactivity on type 2 diabetes mellitus burden in Oman: insights from mathematical modeling

24. Early screening for foot problems in people with diabetes is the need of the hour: ‘Save the Feet and Keep Walking Campaign’ in India

25. Single-cell transcriptomic analysis reveals the antiangiogenic role of Mgarp in diabetic retinopathy

26. Surrogate measures of first-phase insulin secretion versus reference methods intravenous glucose tolerance test and hyperglycemic clamp: a systematic review and meta-analyses

27. Environmental Determinants of Islet Autoimmunity (ENDIA) longitudinal prospective pregnancy to childhood cohort study of Australian children at risk of type 1 diabetes: parental demographics and birth information

28. Effects of insonification on repairing the renal injury of diabetic nephropathy rats

29. Assessment of neuropathy subtypes in type 1 diabetes

30. Plasma sphingolipids mediate the association between gut microbiome composition and type 2 diabetes risk in the HELIUS cohort: a case-cohort study

31. Predictors of readmission and mortality in adults with diabetes or stress hyperglycemia after initial hospitalization for COVID-19

32. Unveiling contrasts in microbiota response: A1c control improves dysbiosis in low-A1c T2DM, but fails in high-A1c cases—a key to metabolic memory?

33. A randomized, placebo-controlled study of chitosan gel for the treatment of chronic diabetic foot ulcers (the CHITOWOUND study)

34. Assessing the use of sodium-glucose cotransporter 2 inhibitor in patients with type 2 diabetes mellitus and chronic kidney disease in tertiary care: a SwissDiab Study

35. Precision Medicine to Redefine Insulin Secretion and Monogenic Diabetes-Randomized Controlled Trial (PRISM-RCT) in Chinese patients with young-onset diabetes: design, methods and baseline characteristics

36. Impact of oxidative stress on myocardial performance in patients with diabetes: a focus on subclinical left ventricular dysfunction

37. Prevalence and risk factors for diabetic retinopathy at diagnosis of type 2 diabetes: an observational study of 77 681 patients from the Swedish National Diabetes Registry

38. Identifying subtypes of type 2 diabetes mellitus with machine learning: development, internal validation, prognostic validation and medication burden in linked electronic health records in 420 448 individuals

39. Within and post-trial effects of an intensive lifestyle intervention on kidney disease in adults with overweight or obesity and type 2 diabetes mellitus: a secondary analysis of the Look AHEAD clinical trial

40. Kidney outcomes of SGLT2 inhibitors among older patients with diabetic kidney disease in real-world clinical practice: the Japan Chronic Kidney Disease Database Ex

41. Enhancing equity in access to automated insulin delivery systems in an ethnically and socioeconomically diverse group of children with type 1 diabetes

42. Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis

43. Unveiling potential therapeutic targets for diabetes-induced frozen shoulder through Mendelian randomization analysis of the human plasma proteome

44. Plasma angiotensin-converting enzyme 2 (ACE2) is a marker for renal outcome of diabetic kidney disease (DKD) (U-CARE study 3)

45. Comparing the effectiveness and cost-effectiveness of sulfonylureas and newer diabetes drugs as second-line therapy for patients with type 2 diabetes

46. Prospective associations between breast feeding, metabolic health, inflammation and bone density in women with prior gestational diabetes mellitus

47. Clinical perspectives on the frequency of hypoglycemia in treat-to-target randomized controlled trials comparing basal insulin analogs in type 2 diabetes: a narrative review

48. Glucose levels measured with continuous glucose monitoring in uncomplicated pregnancies

49. Multidisciplinary proactive e-consults to improve guideline-directed medical therapies for patients with diabetes and chronic kidney disease: an implementation study

50. Effects of metformin, saxagliptin and repaglinide on gut microbiota in high-fat diet/streptozocin-induced type 2 diabetic mice

Catalog

Books, media, physical & digital resources